
Achieve Life Sciences Investor Relations Material
Latest events

Q3 2024
Achieve Life Sciences
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Achieve Life Sciences Inc
Access all reports
Achieve Life Sciences, Inc. is a biopharmaceutical company focused on the development and commercialization of therapies to aid in smoking cessation. The company’s lead product candidate is based on cytisinicline, a plant-based alkaloid that is being developed to help people quit smoking by reducing nicotine cravings and withdrawal symptoms. Achieve Life Sciences is engaged in clinical trials to advance its therapeutic offerings aimed at addressing nicotine addiction. The company is headquartered in Seattle, United States, and its shares are listed on the NASDAQ.
Latest articles
)
Robert G. Hagstrom: Darwinian Investing and Multidisciplinary Wisdom
Robert G. Hagstrom, author of The Warren Buffett Way, explores how interdisciplinary thinking shapes his investing, from Adler's reading to Darwinian markets.
7 Feb 2025
)
Quartr Brings Stories Behind the Numbers to Light
Quartr simplifies access to IR material and puts qualitative insights and company narratives front and center.
3 Feb 2025
)
The Evolution of the IRO Role: Staying Informed and Strategic With Quartr Pro
Staying informed is critical for IROs. Quartr Pro simplifies gathering market insights and narrative positioning with unprecedented speed and precision.
3 Feb 2025
Ticker symbol
ACHV
Country
🇺🇸 United States